TY - JOUR
T1 - Mentorship Experiences Are Not All the Same
T2 - A Survey Study of Oncology Trainees and Early-Career Faculty
AU - Idossa, Dame
AU - Velazquez, Ana I.
AU - Horiguchi, Miki
AU - Alberth, Julia
AU - Abuali, Inas
AU - Smith-Graziani, Demetria
AU - De Lima Lopes, Gilberto
AU - Lubner, Sam
AU - Florez, Narjust
N1 - Publisher Copyright:
© American Society of Clinical Oncology.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - PURPOSEPhysician workforce diversity can be a driver of institutional excellence, improving innovation and reducing health disparities. However, the current diversity of the hematology/oncology (HO) workforce does not reflect that of the US population.METHODSWe conducted a cross-sectional online survey of current trainees and faculty within 5 years of completing terminal training in oncology specialties.RESULTSOf the 306 respondents, 64 (21%) were under-represented in medicine (URiM) and 161 (53%) identified as male. URiM participants were less likely to have a primary mentor (66%) than non-URiM participants (80%; P =.015). Among those who had a primary mentor, URiMs met less frequently (once every 3-6 months or less) with their mentor (19% v 7% non-URiM; P =.003). Furthermore, URiMs were more likely to report having mentors outside their own institution (47% v 40% non-URiM; P =.002) and making compromises to gain access to mentorship (36% v 23% non-URiM; P & 0.001). URiMs were also less likely to apply for grants (34% v 42% non-URiM; P =.035) and awards (28% v 43% non-URiM; P =.019). In multivariable models, URiM individuals were more likely to make compromises to gain access to mentors (odds ratio [OR], 1.96; 95% CI, 1.01 to 3.82) and this remained significant for females (OR, 2.17; 95% CI, 1.26 to 3.75).CONCLUSIONURiM individuals may be less likely to have effective mentorship and apply for awards and grant support. Understanding the challenges of URiM trainees can help shape training environments in academic medicine to ensure that they are grounded in diversity, inclusion, and retention.
AB - PURPOSEPhysician workforce diversity can be a driver of institutional excellence, improving innovation and reducing health disparities. However, the current diversity of the hematology/oncology (HO) workforce does not reflect that of the US population.METHODSWe conducted a cross-sectional online survey of current trainees and faculty within 5 years of completing terminal training in oncology specialties.RESULTSOf the 306 respondents, 64 (21%) were under-represented in medicine (URiM) and 161 (53%) identified as male. URiM participants were less likely to have a primary mentor (66%) than non-URiM participants (80%; P =.015). Among those who had a primary mentor, URiMs met less frequently (once every 3-6 months or less) with their mentor (19% v 7% non-URiM; P =.003). Furthermore, URiMs were more likely to report having mentors outside their own institution (47% v 40% non-URiM; P =.002) and making compromises to gain access to mentorship (36% v 23% non-URiM; P & 0.001). URiMs were also less likely to apply for grants (34% v 42% non-URiM; P =.035) and awards (28% v 43% non-URiM; P =.019). In multivariable models, URiM individuals were more likely to make compromises to gain access to mentors (odds ratio [OR], 1.96; 95% CI, 1.01 to 3.82) and this remained significant for females (OR, 2.17; 95% CI, 1.26 to 3.75).CONCLUSIONURiM individuals may be less likely to have effective mentorship and apply for awards and grant support. Understanding the challenges of URiM trainees can help shape training environments in academic medicine to ensure that they are grounded in diversity, inclusion, and retention.
UR - http://www.scopus.com/inward/record.url?scp=85171202367&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85171202367&partnerID=8YFLogxK
U2 - 10.1200/OP.22.00643
DO - 10.1200/OP.22.00643
M3 - Article
C2 - 37192431
AN - SCOPUS:85171202367
SN - 2688-1527
VL - 19
SP - 808
EP - 818
JO - JCO Oncology Practice
JF - JCO Oncology Practice
IS - 9
ER -